Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients

BACKGROUND: The demonstration of EGFR T790M gene mutation in plasma is crucial to assess the eligibility of Non Small Cell Lung Cancer (NSCLC) patients, who have acquired resistance to first or second generation Tyrosine Kinase Inhibitors (TKIs), to receive a subsequent treatment with osimertinib. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Dono, Mariella, De Luca, Giuseppa, Lastraioli, Sonia, Anselmi, Giorgia, Dal Bello, Maria Giovanna, Coco, Simona, Vanni, Irene, Grossi, Francesco, Vigani, Antonella, Genova, Carlo, Ferrarini, Manlio, Ravetti, Jean Louis, Zupo, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487061/
https://www.ncbi.nlm.nih.gov/pubmed/31029076
http://dx.doi.org/10.1186/s10020-019-0082-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487061/
https://www.ncbi.nlm.nih.gov/pubmed/31029076
http://dx.doi.org/10.1186/s10020-019-0082-5

Ejemplares similares